Spruce Biosciences

Clinical stage biopharma developing rare diseases affecting the stress pathway (HPA axis)

placeSan Francisco, California, United States calendar_todayFounded 2014 groups15 employees language sprucebiosciences.com

Registered entities

Social engagement

Social engagement: 4.1K social following, 10 posts in the last 12 months — above the industry median.

Investor mix

12 investors on record; lead investors include Omega Funds, Abingworth, Novo Holdings; 1 has since exited.

Investor typeCountShare
Venture capital867%
Private equity18%
Other / undisclosed325%

Recent activity

29 Jun 2026
Milestone
regulatory
22 Jun 2026
Leadership hire
Vice President, Medical Affairs
15 Jun 2026
Leadership hire
Vice President, Marketing
Coming soon